Anticancer agent 187
Anticancer agent 187 (Compound 4) is an anticancer agent that can target sarcoma cells in tumor-bearing mouse models. Anticancer agent 187 exhibits cytotoxic activity against HepG2, Caco2, and MCF-7 cells[1].
Product Specifications
CAS Number
9007-83-4
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-187.html
Solubility
10 mM in DMSO
Smiles
O=C(OCC)C1=C(C)N=C(N)C(C#N)=C1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)CNC2=CC=CC(O)=C2
Molecular Formula
C21H26N4O7
Molecular Weight
446.45
References & Citations
[1]Mehany M M, et al. Novel pyridine bearing pentose moiety-based anticancer agents: design, synthesis, radioiodination and bioassessments[J]. Scientific Reports, 2024, 14 (1) : 2738.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0012445-01 10 µg
Recombinant HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Sign In for Pricing
View Details TRV-0012445-02 50 µg
Recombinant HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Sign In for Pricing
View Details TRV-0012445-03 100 µg
Recombinant HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Sign In for Pricing
View Details TRV-0012445-04 200 µg
Recombinant HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Sign In for Pricing
View Details TRV-0012445-05 500 µg
Recombinant HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Sign In for Pricing
View Details TRV-0012445-06 1 mg
Recombinant HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
Sign In for Pricing
View Details